222 reports of this reaction
2.2% of all TASIMELTEON reports
#9 most reported adverse reaction
FATIGUE is the #9 most commonly reported adverse reaction for TASIMELTEON, manufactured by Vanda Pharmaceuticals Inc.. There are 222 FDA adverse event reports linking TASIMELTEON to FATIGUE. This represents approximately 2.2% of all 9,924 adverse event reports for this drug.
Patients taking TASIMELTEON who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for TASIMELTEON, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for TASIMELTEON:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 222 FDA reports for TASIMELTEON. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.2% of all adverse event reports for TASIMELTEON, making it a notable side effect.
If you experience fatigue while taking TASIMELTEON, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.